Phosphorylation of connexin43 on serine 306 regulates electrical coupling
Background
Phosphorylation is a key regulatory event in controlling the function of the cardiac gap junction protein connexin43 (Cx43). Three new phosphorylation sites (S296, S297, S306) have been identified on Cx43; two of these sites (S297 and S306) are dephosphorylated during ischemia. The functional significance of these new sites is currently unknown.
Objective
The purpose of this study was to examine the role of S296, S297, and S306 in the regulation of electrical intercellular communication.
Methods
To mimic constitutive dephosphorylation, serine was mutated to alanine at the three sites and expressed in HeLa cells. Electrical coupling and single channel measurements were performed by double patch clamp. Protein expression levels were assayed by western blotting, localization of Cx43, and phosphorylation of S306 by immunolabeling. Free hemichannels were assessed by biotinylation.
Results
Macroscopic conductance in cells expressing S306A was reduced to 57% compared to wild type (WT), whereas coupling was not significantly changed in cells expressing either S296A or S297A. S306A-expressing cells displayed similar protein and free hemichannel abundance compared to WT Cx43, whereas the fractional area of plaques in cell-to-cell interfaces was increased. However, single channel measurements showed a WT Cx43 main state conductance of 119 pS, whereas the main state conductance of S306A channels was reduced to 95 pS. Furthermore, channel gating was affected in S306A channels.
Conclusion
Lack of phosphorylation at serine 306 results in reduced coupling, which can be explained by reduced single channel conductance. We suggest that dephosphorylation of S306 partly explains the electrical uncoupling seen in myocardial ischemia.
Keywords: Gap junction, Connexin43, Phosphorylation, Ischemia, Single channel
Abbreviations: Ab, antibody, BSA, bovine serum albumin, Cx43, connexin43, PBS, phosphate buffered saline, PKC, protein kinase C, PMSF, phenylmethanesulfonyl fluoride, WT, wild type
To access this article, please choose from the options below
The last two authors contributed equally to this study.
This work was supported by The Danish National Research Foundation; The John and Birthe Meyer Foundation; The Danish Health Sciences Research Councils; The Velux Foundation; The Danish Heart Association; The Novo Nordisk Foundation; and The A.P. Møller Foundation. M.D. was supported by NIH grants GM057691-12, HL039707, and HL087226.
PII: S1547-5271(09)00824-8
doi:10.1016/j.hrthm.2009.07.043
© 2009 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
